Key result
Serological screening of 360 dromedary camels in Nigeria revealed a 10.83% prevalence of antibodies against foot-and-mouth disease virus non-structural proteins, indicating natural exposure.
Cross-Sectional (n=360)
Yes
This study provides the first serological evidence of FMD antibodies in dromedaries in West Africa, suggesting they may be susceptible to FMDV infection.
Indicates FMDV exposure risk in Nigerian camels; leaves open their epidemiological role and requires prospective studies before control implications.
Foot-and-mouth-disease (FMD) is one of the most important trans-boundary animal diseases in Africa with outbreaks occurring mostly in cattle. However, there is scarcity of information on the potential role of camels in the epidemiology of FMD virus in West Africa. A total of 360 camel sera collected from abattoir in Nigeria from different geo-political zones (North, West and East) were screened for the presence of antibodies produced against 3ABC non-structural proteins (NSP) for foot-mouth-disease virus (FMDV) using a commercially available kit prioCHECK® FMDV NS. Thirty nine, (10.83%) out of the 360 sera samples were tested positive for 3ABC NSP ELISA. The 39 positive samples were further subjected for sero-typing using solid-phase competitive ELISA (SPCE) for antibodies to FMDV serotype A and O (Solid-Phase Competitive ELISA, IZSLER Brescia-Italy). Two out of the 39 sera samples were positive for serotype A and the remaining were negative for both serotype A and O. This appears to be the first report of evidence of FMD antibodies in dromedaries in West Africa and that dromedaries may be susceptible to FMDV infection.
No takes yet. Share an insight, caveat, or question.
Ularamu et al. (2015) conducted a cross-sectional in Foot-and-mouth disease (FMD) (n=360). Natural exposure to FMDV was evaluated on Seroprevalence of antibodies against FMDV non-structural proteins (NSP) (95% CI 7.93-14.37). Serological screening of 360 dromedary camels in Nigeria revealed a 10.83% prevalence of antibodies against foot-and-mouth disease virus non-structural proteins, indicating natural exposure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: